“…In human vaccine trials, partially lysed gonococci, purified pilin, and purified porin were shown to be immunogenic, but all failed to elicit protection upon subsequent natural exposure (7,19,46). The lack of protective immunity is likely due, in part, to the capacity of many gonococcal surface antigens to undergo high-frequency phase and antigenic variation (38). With the increasing emergence of drug-resistant strains (9) and the disturbing finding that human immunodeficiency virus transmission is increased with concurrent gonococcal infection (11,27), the search for effective vaccine antigens has become more urgent.…”